Next, we aimed to get deeper insights of the p190-specific transcriptional and signaling pathways in hematopoietic progenitor cell lines to overcome the limitation of scarcity of p190-CML samples. The gene discussed is CNTNAP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.